Meridian Bioscience's Q2 Revenues Rise 16 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported second-quarter revenue growth of 16 percent with double-digit growth for its life science and US diagnostics business.

The Cincinnati-based diagnostics firm reported total revenues of $47.4 million for the three-month period ended March 31, up 16 percent from $41.1 million for the first quarter of 2011. It beat the consensus Wall Street estimate of $44.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.